ISB News

Promotion: Michael Hoopmann Becomes Senior Research Scientist

Congratulations to Dr. Michael Hoopmann, of the Moritz Lab, who has been promoted to Senior Research Scientist. His research is focused on proteomics technology and methods development, having been trained in both instrumentation and software data analysis, with particular focus on high-resolution mass spectrometry. His current interests are in the development of advanced algorithms for discovery-based proteomics. He is the developer of the Kojak algorithm, a versatile, open-source software application for the discovery of protein-protein interactions through shotgun-based mass spectrometry. Dr. Hoopmann is also a contributor to the Trans-Proteomic Pipeline suite of software solutions for mass spectrometry data analysis.

Recent Articles

  • Tackling Lyme Disease with Immunity

    It’s Lyme disease season in many areas of the United States, including the Northeast, the Midwest, and some places on the West Coast. In our latest Research Roundtable event, ISB Associate Professor Dr. Naeha Subramanian discussed the latest Lyme disease research conducted in her lab.

  • Wei Lab

    New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty Acids

    A recently developed method by the Wei Lab at Institute for Systems Biology (ISB) and University of California, Riverside provides new insights into cancer biology by allowing researchers to show how fatty acids are absorbed by single cells. This work was published in the Journal of the American Chemical Society.

  • Glioblastoma tumor slice and corresponding density map

    Looking at Tumors Through a New Lens

    To improve the efficacy of neoadjuvant immune checkpoint blockade against glioblastoma, researchers are looking for vulnerabilities in surgically removed tissues – a difficulty due to the vast differences within the tumor and between patients. To address this, ISB researchers and their collaborators developed a new way to study tumors.